Clinical Trial Update: Pirfenidone in the Chronic Hypersensitivity Pneumonitis Treatment [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update notes Phase 2 and Phase 3 studies of pirfenidone for chronic hypersensitivity pneumonitis/extrinsic allergic alveolitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypersensitivity Pneumonitis
• Pulmonary Fibrosis

Drugs mentioned

• PIRFENIDONE (pirfenidone)

Snippet

Sponsor: Grupo Medifarma, S. A. de C. V. | Conditions: Alveolitis Extrinsic Allergic, Pulmonary Fibrosis | Phase 2, Phase 3 | Status: UNKNOWN